Cargando…
P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430627/ http://dx.doi.org/10.1097/01.HS9.0000846272.91489.2d |
| _version_ | 1784779822992457728 |
|---|---|
| author | Derman, B. Rosenblatt, J. Avigan, D. Major, A. Rampurwala, M. Barnidge, D. Stefka, A. Jiang, K. Jakubowiak, A. |
| author_facet | Derman, B. Rosenblatt, J. Avigan, D. Major, A. Rampurwala, M. Barnidge, D. Stefka, A. Jiang, K. Jakubowiak, A. |
| author_sort | Derman, B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430627 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94306272022-08-31 P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA Derman, B. Rosenblatt, J. Avigan, D. Major, A. Rampurwala, M. Barnidge, D. Stefka, A. Jiang, K. Jakubowiak, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430627/ http://dx.doi.org/10.1097/01.HS9.0000846272.91489.2d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Derman, B. Rosenblatt, J. Avigan, D. Major, A. Rampurwala, M. Barnidge, D. Stefka, A. Jiang, K. Jakubowiak, A. P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA |
| title | P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA |
| title_full | P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA |
| title_fullStr | P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA |
| title_full_unstemmed | P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA |
| title_short | P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA |
| title_sort | p847: mrd by mass spectrometry in peripheral blood and next generation sequencing in bone marrow in a phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone for multiple myeloma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430627/ http://dx.doi.org/10.1097/01.HS9.0000846272.91489.2d |
| work_keys_str_mv | AT dermanb p847mrdbymassspectrometryinperipheralbloodandnextgenerationsequencinginbonemarrowinaphase2studyofdaratumumabcarfilzomiblenalidomideanddexamethasoneformultiplemyeloma AT rosenblattj p847mrdbymassspectrometryinperipheralbloodandnextgenerationsequencinginbonemarrowinaphase2studyofdaratumumabcarfilzomiblenalidomideanddexamethasoneformultiplemyeloma AT avigand p847mrdbymassspectrometryinperipheralbloodandnextgenerationsequencinginbonemarrowinaphase2studyofdaratumumabcarfilzomiblenalidomideanddexamethasoneformultiplemyeloma AT majora p847mrdbymassspectrometryinperipheralbloodandnextgenerationsequencinginbonemarrowinaphase2studyofdaratumumabcarfilzomiblenalidomideanddexamethasoneformultiplemyeloma AT rampurwalam p847mrdbymassspectrometryinperipheralbloodandnextgenerationsequencinginbonemarrowinaphase2studyofdaratumumabcarfilzomiblenalidomideanddexamethasoneformultiplemyeloma AT barnidged p847mrdbymassspectrometryinperipheralbloodandnextgenerationsequencinginbonemarrowinaphase2studyofdaratumumabcarfilzomiblenalidomideanddexamethasoneformultiplemyeloma AT stefkaa p847mrdbymassspectrometryinperipheralbloodandnextgenerationsequencinginbonemarrowinaphase2studyofdaratumumabcarfilzomiblenalidomideanddexamethasoneformultiplemyeloma AT jiangk p847mrdbymassspectrometryinperipheralbloodandnextgenerationsequencinginbonemarrowinaphase2studyofdaratumumabcarfilzomiblenalidomideanddexamethasoneformultiplemyeloma AT jakubowiaka p847mrdbymassspectrometryinperipheralbloodandnextgenerationsequencinginbonemarrowinaphase2studyofdaratumumabcarfilzomiblenalidomideanddexamethasoneformultiplemyeloma |